Remaining quiet on this one and just watching the volume. No big changes yet. Skeptical that we'll see anything big this quarter, and that makes me slightly edgy. We need cash, big time. We're either about to see a big adjustment in sell through, a debt facility, action of partnership front or a CR.
Whatever the case we need $. No two ways about it.
- Forums
- ASX - By Stock
- AVR
- Ann: Annual Report to shareholders
Ann: Annual Report to shareholders, page-62
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$9.50 |
Change
-0.410(4.14%) |
Mkt cap ! $202.9M |
Open | High | Low | Value | Volume |
$9.50 | $9.61 | $9.31 | $85.90K | 9.044K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 642 | $9.50 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$9.67 | 923 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 700 | 9.500 |
1 | 943 | 9.410 |
1 | 99 | 9.310 |
1 | 2000 | 9.300 |
2 | 412 | 9.200 |
Price($) | Vol. | No. |
---|---|---|
9.670 | 923 | 6 |
9.680 | 161 | 1 |
9.690 | 180 | 1 |
9.700 | 180 | 1 |
9.910 | 13 | 1 |
Last trade - 11.58am 13/11/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online